Drawing for LASAC

USPTO serial 76250742

LASAC

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
HALLORAN, COLLEEN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LASAC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gilbert Lee Sandler

GILBERT LEE SANDLER SANDLER TRAVIS & ROSENBERG PA5200 BLUE LAGOON DR STE 600MIAMI, FL 33126-7002UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical and medicinal preparations for the prevention and treatment of vascular, physiological and emotional conditions, liver, stomach and gallbladder disorders, gastritis, jaundice, Hepatitis B, gallstones, thyroid and parathyroid disorders, perspiration, cancer, vaginally transmitted infections, infectious diseases, inflammation and inflammatory disease, respiratory disorders and diseases, renal disorders and diseases, auto-immune diseases, autoimmune diseases or disorders, premenstrual syndrome, menopausal syndrome, endometriosis, diabetes, cardiovascular diseases, sexual dysfunction, endocrine diseases, gastrointestinal diseases, urological diseases and disorders, viral diseases, immune system disorders, central nervous system disorders, peripheral nervous system disorders, acne and other skin affections, attention deficit disorder, ear related disorders, strokes, burns, opthamological conditions and diseases, Parkinson's disease, migraines, snoring, multiple sclerosis, psoriasis, arthritis and surgical adhesions; antibacterial pharmaceuticals; cardiovascular pharmaceuticals; vitamins, herbal and homeopathic medicinal preparations and pharmaceuticals; ocular pharmaceuticals; inducers of erections; psychotropics; allergy tablets, pills and capsules; antibiotic tablets, pills, capsules and liquid preparations; sleeping pills and tablets; diet pills; astringents for medicinal purposes; bacteriostats for medicinal purposes; ginseng for medicinal use; sugar replacement for medicinal purposes; antihistamines; auto immune suppressants; oral analgesics; mouthwashes for medical purposes; estrogens; androgens; medicated skin and hair care preparations; disinfectants; astringents; analgesics; medicated bath salts; medicated sunburn and skin lotions; diuretics; anorexigenics; fungicidal agents; hormonal agents; sedatives; antimicrobial and antibacterial preparations; medicated topical preparations for human use for dryness, cold sores, burns, itching, lip and skin care; medicated skin cleaning preparations; anticoagulants; antidepressants; appetite suppressants; topical antiseptic and anesthetic liquid, spray, cream, wipes, gel and ointment; pharmaceutical preparations for use with human patients undergoing dialysis, chemotherapy and radiation therapies; pain control preparations and anesthesiaABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 29, 2003OP.TOPPOSITION TERMINATED NO. 999999—
Apr 29, 2003OP.SOPPOSITION SUSTAINED NO. 999999—
Feb 22, 2003ABN5ABANDONMENT - AFTER PUBLICATION—
Feb 3, 2003OP.IOPPOSITION INSTITUTED NO. 999999—
Dec 12, 2002MAILPAPER RECEIVED—
Nov 5, 2002ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 8, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 18, 2002NPUBNOTICE OF PUBLICATION—
Apr 26, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 8, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 10, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 8, 2001DOCKASSIGNED TO EXAMINER—
Jul 30, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance